Abstract:This was a retrospective, unmatched case control, laboratory-based study, investigating the impact of human immunodeficiency virus (HIV) infection on the outcome of routine laboratory detection of HBsAg and prevalence of active HBV infection in 295 samples from 167 HIV-positive and 128 HIV-negative patients. The samples were tested for HBV (HBsAg, anti-HBc, anti-HBs, HBeAg and anti-HBe) and anti-HIV 1 and 2 (Axsym assays, Abbott Laboratories), as part of routine diagnosis. A nested PCR assay, with detection limit of 800 copies/ml and employing independent sets of primers to core and surface genes, was used to investigate HBV DNA. Quantification of HBV DNA was determined with the Cobas Amplicor HBV Monitor assay (Roche Diagnostics). Of the 295 samples, the frequency of anti-HBc was almost similar; 82% for the HIV-negatives and 85% for the HIV-positives, indicating that both groups were equally exposed to HBV infection. The HIV-positives had a higher rate of anti-HBs (76.0% versus 47.7%) and a lower rate of HBsAg carriage (16.2% versus 35.2%), suggesting that HIV-positive individuals are less likely to experience chronic HBV infection. However, analysis of HBV DNA indicated that many of the anti-HBs positives (20.5% versus 8.2%) and HBsAg-negatives (22.1% versus 2.4%) had active HBV infection in the HIV-positive group. There was a statistically significant difference in the prevalence of HBV DNA in the HBsAg-negatives between the two groups (Odds ratio: 11.52; chi-square: p=0.00006). Additionally, 33.3% (5/15) of sera with "anti-HBc alone" serological pattern were HBV viremic in the HIV-positive group, compared to 0% (n=31) in the HIV-negatives. Quantification of HBV DNA from HBsAg-negative/HIV-positive patients demonstrated low level HBV viremia (below 10,000 copies/ml). In conclusion, these findings strongly support that HIV infection is a risk factor for occult HBV infections.

S2484 Vanishing Bile Duct Syndrome Resulting From HIV Viremia: A Case Report

Kaposi’s Sarcoma Manifested As Lower Gastrointestinal Bleeding in a HIV/HBV-co-infected Liver Cirrhosis Patient: A Case Report

Epstein-Barr virus associated hepatic smooth muscle tumor in a patient with acquired immunodeficiency syndrome A case report

S4299 A Clinical Puzzle: A Case of Vanishing Bile Duct Syndrome

S2376 A Curious Case of AIDS Cholangiopathy

Vanishing Bile Duct Syndrome: A Differential Diagnosis for Painless Jaundice

Vanishing bile duct syndrome in a Hodgkin's lymphoma patient with fatal outcome despite lymphoma remission

S4576 Unique Case of Vanishing Bile Duct Syndrome Exacerbated by Noncompliance

Acalculous cholecystitis associated with cytomegalovirus and sclerosing cholangitis in a patient with acquired immunodeficiency syndrome.

Gastrointestinal Kaposi Sarcoma without Dermatological Lesions: A Case Report

S3712 Massive Hematochezia Unveiling Diffuse Large B-Cell Lymphoma in an Untreated HIV-Positive Patient

A Challenging Diagnosis of HHV-8-Associated Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, in a Young Man with Newly-Diagnosed HIV

S4905 From Lymphoma to MAC: Uncovering the True Cause of Chronic Diarrhea in an HIV Patient

S1029 Outcomes of HIV Patients With Variceal Upper Gastrointestinal Bleeding in the United States; An Analysis From the National Inpatient Sample

S5087 Chicken Pox of the Gut in a Patient With Advanced HIV

[Spontaneous regression of HIV-associated EBV-positive mucocutaneous ulcer due to immune reconstruction with antiretroviral therapy]

Unusual demyelinating disease in a patient with HIV infection

Acute Hepatitis Due to Primary Human Immunodeficiency Virus Infection

S4407 Managing Granulomatous Liver Disease in HIV/AIDS: A Case Study

Intestinal perforation caused by Epstein-Barr virus-positive primary diffuse large B-cell lymphoma in a patient with HIV

High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa